The Royal Victoria Infirmary is a 673-bed tertiary referral centre in Newcastle upon Tyne, England. The hospital is part of the Newcastle upon Tyne Hospitals NHS Foundation Trust and is a teaching hospital for the University of Newcastle upon Tyne.

There are 620 beds in Royal Victoria Infirmary.

During the past decade, Royal Victoria Infirmary conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 42 clinical trials were completed, i.e. on average, 45.7% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 32 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Victoria Infirmary" #1 sponsor was "Hoffmann-La Roche" with 17 trials, followed by "Vertex Pharmaceuticals Incorporated" with 6 trials sponsored, "University of Birmingham" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Newcastle-upon-Tyne Hospitals NHS Trust" with 4 trials sponsored. Other sponsors include 105 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Victoria Infirmary" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Cancer Research UK" with 3 trials as a collaborator, "NHS Lothian" with 3 trials as a collaborator, "National Health and Medical Research Council, Australia" with 3 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator. Other collaborators include 116 different institutions and companies that were collaborators in the rest 112 trials.

According to Clinical.Site data, the most researched conditions in "Royal Victoria Infirmary" are "Cystic Fibrosis" (8 trials), "Ulcerative Colitis" (8 trials), "Acromegaly" (3 trials), "Diabetic Macular Edema" (3 trials) and "Duchenne Muscular Dystrophy" (3 trials). Many other conditions were trialed in "Royal Victoria Infirmary" in a lesser frequency.

Most popular intervention types in "Royal Victoria Infirmary" are "Drug" (96 trials), "Other" (21 trials), "Biological" (16 trials), "Procedure" (13 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Sham Procedure" (7 trials), "IVA" (6 trials), "Faricimab" (5 trials) and "Ifosfamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Royal Victoria Infirmary" are 131 trials for "All" genders, 8 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 41 active trials in "Royal Victoria Infirmary". 1 are not yet recruiting, 19 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 82 completed trials in Royal Victoria Infirmary, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Victoria Infirmary, 13 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 13 trials that are defined as “Not Applicable".